-Press Release by Association for Democratic Reforms (ADR) dated 25 March, 2019 The Association for Democratic Reforms (ADR) commissioned perhaps the largest ever Voter Survey in any country. The survey was conducted between October 2018 and December 2018, prior to the General Elections to the Lok Sabha 2019. It covered 534 Lok Sabha constituencies with 2,73,487 voters participating in this exercise spread among various demographics. The three main objectives of...

-The Hindu There is obfuscation over both the existence of a jobs crisis and the diagnosis of it It is well established that India is staring at a massive jobs crisis. Every single survey points to jobs as the biggest issue concerning voters, especially the youth. Yet, the Prime Minister and the government steadfastly refuse to even acknowledge this issue, let alone address it. India’s jobs crisis is an economic issue, not a...

Recent studies and media reports have confirmed that Indian farmers are facing non-remunerative and sometimes falling prices. A past news alert by the Inclusive Media for Change team indicated deflation in wholesale prices of 8 kharif crops (viz. maize, arhar, moong, urad, groundnut, soybean, sunflower seed and Niger seed) on average between 2016-17 and 2018-19. Based on data analysis, that news alert also demonstrated how the rural areas have witnessed...

-Newsclick.in New GDP numbers show the deep agrarian crisis and an economy in doldrums, while unemployment continues to grow. Advance estimates of Gross Domestic Product (GDP) for the current year 2018-19, and estimates for the third quarter (Sept-Dec 2018) show unmistakeable signs of a slowing economy, despite the flawed method of calculating these estimates. The country’s economy will grow by 7% in the current year which will end this March. Last year...

-The Times of India NEW DELHI: The government has capped trade margins of 42 cancer drugs at 30% expanding the span of price control to curtail undue profiteering by chemists and drug stockists on various medicines which were so far outside price regulation. The move is expected to bring major relief to around 1.5 million cancer patients in India reeling under exponentially high treatment cost leading to heavy out-of-pocket expenditure. In a detailed...